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Early-use activity during circuit-speciﬁc critical periods reﬁnes brain circuitry by the coupled
processes of eliminating inappropriate synapses and strengthening maintained synapses.
We theorize these activity-dependent (A-D) developmental processes are speciﬁcally
impaired in autism spectrum disorders (ASDs). ASD genetic models in both mouse and
Drosophila have pioneered our insights into normal A-D neural circuit assembly and
consolidation, and how these developmental mechanisms go awry in speciﬁc genetic
conditions. The monogenic fragile X syndrome (FXS), a common cause of heritable
ASD and intellectual disability, has been particularly well linked to defects in A-D critical
period processes. The fragile X mental retardation protein (FMRP) is positively activity-
regulated in expression and function, in turn regulates excitability and activity in a
negative feedback loop, and appears to be required for the A-D remodeling of synaptic
connectivity during early-use critical periods.TheDrosophila FXSmodel has been shown to
functionally conserve the roles of human FMRP in synaptogenesis, and has been centrally
important in generating our current mechanistic understanding of the FXS disease state.
Recent advances inDrosophila optogenetics, transgenic calcium reporters, highly-targeted
transgenic drivers for individually-identiﬁed neurons, and a vastly improved connectome of
the brain are now being combined to provide unparalleled opportunities to both manipulate
and monitor A-D processes during critical period brain development in deﬁned neural
circuits. The ﬁeld is now poised to exploit this new Drosophila transgenic toolbox for
the systematic dissection of A-D mechanisms in normal versus ASD brain development,
particularly utilizing the well-established Drosophila FXS disease model.
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INTRODUCTION
The recent passing of David Hubel (September 22, 2013) occurs
in the midst of a rich era of research into the activity-dependent
(A-D) formation and reﬁnement of neural circuitry during nor-
mal brain development and in neurodevelopmental disease states.
Hubel and Wiesel’s pioneering studies on monocular deprivation
and activity manipulations in the cat visual system (Hubel and
Wiesel, 1959, 1962, 1970; Wiesel and Hubel, 1963) laid the foun-
dation for our understanding of the A-D assembly and pruning of
synaptic connections. All synapses formed through the reciprocal,
highly orchestrated crosstalk between axons and dendrites face the
bottleneck decision of elimination versus long-term maintenance
and strengthening to form a stable partnership (dendrite stabi-
lization review, Koleske, 2013; intrinsic dendrite development,
Puram and Bonni, 2013). Although early synaptogenesis proceeds
via largely activity-independent mechanisms, the reﬁnement of
synapses is a progressive, A-D process most active during the
early-use critical periods of postnatal development, when synap-
tic arrays are most amenable to pruning and de nova additions
(Hensch, 2004). Following this reﬁnement period, A-D modula-
tion is greatly reduced in themature brain, except formaintenance
of the synaptic plasticity underlying behavioral adaptation (Rice
and Barone, 2000; rodent visual cortex, Nataraj and Turrigiano,
2011). Recent advances in biotechnology provide high-ﬁdelity
readouts of neural activity, as well as precise, non-invasive
methods for the bidirectional manipulation of neural activity
(Chen et al., 2013; Lin et al., 2013b), generating the means to
study A-D developmental processes at a previously inconceivable
level.
Autism spectrum disorders (ASDs) are deﬁned by social inter-
action impairments (Abrahams and Geschwind, 2008), frequently
accompanied by sensory hypersensitivity, cognitive deﬁcits, and
A-D seizures (Kim and Lord, 2012; Kim et al., 2013b). The
improper development of neural circuitry likely lies at the heart
of ASDs, particularly the A-D processes of solidifying appropri-
ate synaptic connections and concomitantly pruning superﬂuous
or incorrect connections (Zoghbi and Bear, 2012). The apparently
diverse genetic bases of the wide spectrumof autism-related disor-
ders makes genetic modeling a challenge (Sanders et al., 2012), but
recent hypotheses suggest that the variety of genetic variants asso-
ciated with ASDs may converge on a more manageable set of core
molecular pathways (Murdoch and State, 2013).With this inmind,
targeted mouse and Drosophila animal model systems harboring
deﬁciencies in ASD-linked human genes often show comparable
phenotypic and behavioral defects to human patients (Hagerman
et al., 2009; van Alphen et al., 2013). Among the strongest primary
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research contributions have come from models of fragile X syn-
drome (FXS), a monogenic disorder that is the leading heritable
contributor to the autism spectrum (Harris et al., 2008; McBride
et al., 2012). In both mouse and Drosophila FXS models, there is
clear and consistent evidence that the causal fragile Xmental retar-
dation protein (FMRP) is directly activity-regulated and in turn
regulates A-D processes of neural circuit assembly and reﬁnement
(Wang et al., 2010a,b; Wondolowski and Dickman, 2013). Pre-
clinical studies with these animal models have already advanced
to a number of human clinical trials [e.g., metabotropic gluta-
mate receptor (mGluR) therapeutics], and groundbreaking tools
to assess and manipulate A-D synapse and circuit development
showgreat promise towardmajor breakthroughs inASD therapeu-
tic intervention strategies (Akerboom et al., 2013; Paz et al., 2013;
Sukhotinsky et al., 2013).
In this review article, we seek to highlight recent advances
in our understanding of A-D synaptic development in the nor-
mal and ASD brain, particularly focused on recent work from
mouse and Drosophila genetic models. We will only mention
is passing electrophysiological investigations of synaptic plastic-
ity at maturity, which is the focus of many excellent reviews
(Malenka and Bear, 2004; Nelson and Turrigiano, 2008; Castillo
et al., 2011). Likewise, the broad genetic and molecular details of
A-D neural circuit assembly have recently been presented else-
where (Flavell and Greenberg, 2008; West and Greenberg, 2011;
Ebert and Greenberg, 2013). Our main focus will be on the
A-D basis of ASDs, and particularly on FXS, as the leading her-
itable contributor to this neurodevelopmental disease condition
(Hagerman and Hagerman, 2002). Starting with a brief review
of normal experience-dependent synaptic changes (Part 1), we
will then focus on correlates between the ASD disease state and
A-D circuit formation (Part 2), and ﬁnally ﬁnish with a detailed
review of the recent technological advances for the manipulation
and monitoring of A-D processes (Part 3) during neural circuit
development.
PART 1: NORMAL ACTIVITY-DEPENDENT
NEURODEVELOPMENT
Hebb (1949) theorized that neural activity would code neu-
ral circuit connectivity through a mechanism of coincident
synapse elimination and consolidation. This theory was ﬁrst
tested in the cat visual cortex, with the ﬁrst visual response
recordings made in the 1950s (Bishop and Clare, 1951, 1952,
1955; Clare and Bishop, 1954; Jung, 1958), coincident with
the pioneering work of Kufﬂer (1953) deﬁning ganglion cell
speciﬁcity/organization and producing some of the ﬁrst pri-
mary evidence of higher order processing. Kufﬂer’s students went
on to establish the principles of A-D mechanisms (Figure 1A),
including Horace Barlow’s characterization of selectivity and lat-
eral inhibition in the frog retina (Barlow, 1953a,b), and David
Hubel and Torsten Wiesel’s work on the basis of A-D (and later
experience-dependent) synaptic development in the cat retinal
system. Hubel and Wiesel ﬁrst demonstrated that individual
striatal cortical neurons (primary visual cortex) respond prefer-
entially to slits of light (Hubel and Wiesel, 1959), providing a
mechanism by which cortex organization enables higher order
perception (Hubel and Wiesel, 1962). Their subsequent studies
usingmonocular deprivation revealed profound changes in cortex
development, with active-pathway axons from the lateral genicu-
late nucleus (LGN) dramatically out-competing inactive axons for
cortex innervation of striatal cortical neurons (Wiesel and Hubel,
1963). The LGN innervated by the monocularly deprived retinal
axons was also thinner, demonstrating a sensory experience-
dependent restructuring of the developing neural circuit
(Wiesel and Hubel, 1963).
Hubel and Wiesel went on to perform an extended series of
A-D developmental studies, establishing a critical period for visual
cortical development in kittens, and demonstrating that adult
cats show no comparable experience-dependent morphological
or electrophysiological changes (Wiesel and Hubel, 1963, 1965a,b;
Hubel and Wiesel, 1970; Wiesel, 1982; Cohen and Greenberg,
2008). Following these pioneering studies, A-D morphological
changeswere similarly revealed in other areas of the sensory cortex.
As one example, upon trimming whiskers in speciﬁc rows, axonal
projections in the rat somatosensory cortex were reduced from
non-deprived columns into deprived columns (axons from col-
umn A generally innervate column B; if the B column is deprived
of input, the A axon receives no postsynaptic response and
collapses), and increased horizontal axonal projections between
non-deprived columns (Broser et al., 2008).Whisker trimming on
the rat’s snout from birth leads to a smaller contralateral motor
area that evokes abnormal motor activity, a phenomenon not seen
in adult rats (Huntley, 1997), again indicating a transient devel-
opmental window. Neuromuscular junction (NMJ) innervation
is another classic system for studying A-D remodeling (Schus-
ter, 2006). Motor axons compete to target individual muscle
ﬁbers during the early-use neonatal period (Sanes and Lichtman,
1999), and NMJ development in the ﬁrst couple of neonatal weeks
displays a progression of A-D synapse elimination, functional rein-
forcement, and eventual structural consolidation (Lichtman and
Colman, 2000; Walsh and Lichtman, 2003). Consistently, imped-
ing neural activity results in slowed synaptic reﬁnement in the
mouse neuromusculature, and enhancing activity increases the
rate of development (Thompson, 1985).
Humans show similar mechanisms of A-D neural circuit devel-
opment (Figure 1B). For example, the auditory cortex displays
an early age critical window of experience-dependent matura-
tion, with professional musicians developing asymmetric brain
features when exposed to music before the age of 7. Speciﬁcally,
development of absolute pitch correlates with a larger left planum
temporale (Schlaug et al., 1995), and enlarged cortical representa-
tion of the left hand in dexterous string players (Elbert et al., 1995;
Schlaug et al., 1995). Auditory cortical development may actually
represent a more extensive (or indeﬁnite) critical period, as com-
pared to other sensory modalities (Kilgard and Merzenich, 1998;
Chang and Merzenich, 2003). This relative extension may result
from a late peak of parvalbumin-expressing (PV+) interneurons,
as described in ferret brain development (Gao et al., 2000). The
emergence of these inhibitory interneurons is progressive (Honig
et al., 1996) and vital for the proper formation of cortical circuits
(Figure 1C; Powell et al., 2012). The auditory critical period is
not open ended, however, as childhood ear infections leading to
long-term deﬁcits in auditory perceptual acuity can occur if not
treated before the age of 7 (Popescu and Polley, 2010). These select
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FIGURE 1 | Activity-dependent synaptic remodeling during critical
periods. (A) Progression of dendrite development. Highly dynamic dendrites
occur in the A-D critical period prior to consolidation of relatively stable
mature connections (Kreutz and Sala, 2012). (B) Synapse number changes as
a function of age. Defects in synaptogenesis (formation, pruning, and
stabilization) correlate with onset of speciﬁc neurological disorder classes,
including intellectual disability (1), ASDs (2), schizophrenia (3), and Alzheimer’s
disease (4) (for example, Penzes et al., 2011). (C) Activity-dependent synapse
changes occur during the critical period, in which synaptic partnerships are
solidiﬁed or dissolved prior to consolidation, coinciding with inhibitory
interneuron innervation, progressive myelination and the formation of
extracellular perineuronal nets (Hensch, 2003).
examples illustrate normal A-D development within single sen-
sory modalities. ASD symptomsmaymanifest through faulty A-D
development in a number of sensory systems, with impairments
of higher-order cognition circuitry developing after formation of
primary sensory circuitry (Belmonte et al., 2004; Geschwind and
Levitt, 2007). Although ASD diagnoses focuses on higher order
cognitive tasks such as social communication, language and cog-
nitive development, and repetitive behaviors (Zwaigenbaum et al.,
2013), precursor deﬁcits in primary sensory processing are char-
acteristic (Marco et al., 2011). A more detailed discussion of ASD
phenotypes is presented in Part 2.
CRITICAL PERIODS OF NEURAL CIRCUIT DEVELOPMENT
The highly dynamic nature of synaptic connectivity is largely
a transient feature of neurodevelopment: long-term imaging of
dendritic spines in adult mice reveals that most mature synapses
are relatively stable (Grutzendler et al., 2002). The critical win-
dow (or critical period) theory has emerged to explain the decline
in synaptic dynamics as the brain develops, and as a mechanistic
foundation toward understanding ASD disease states (Figure 1;
Hensch, 2004). A critical period deﬁnes a temporary developmen-
tal window of heightened sensitivity to sensory stimuli, which
drive connectivity changes (Holtmaat and Svoboda, 2009), with
A-D modulation reduced after the window passes, as reﬂected by
the decrease in spine turnover as the brain matures (Trachten-
berg et al., 2002; Holtmaat et al., 2005; Zuo et al., 2005). The key
critical period hallmarks include (1) competition between circuit
elements, (2) neural activity regulation, (3) structural solidiﬁca-
tion of maintained connections, (4) sharply-deﬁned experience-
dependent window, (5) variable/hierarchical timing and duration
Frontiers in Cellular Neuroscience www.frontiersin.org January 2014 | Volume 8 | Article 30 | 3
Doll and Broadie Activity-dependent mechanisms in ASDs
of windows across systems, (6) a diversity of molecular mecha-
nisms underlying A-Dmodulation, (7) emergence and connectiv-
ity of inhibitory neurons, (8) attention/motivation by aminergic
and cholinergic modulation, and (9) the potential for reactivation
in adulthood (Figure 1; Hensch, 2004). Synaptogenesis underlies
these hallmarks in critical periods, and takes place sequentially
through initial axonal/dendritic outgrowth, excess formation of
synapses, and subsequent pruning through A-Dmaturation (Katz
and Shatz, 1996; West and Greenberg, 2011). Although synapse
regulation continues throughout life (Holtmaat et al., 2005; Grillo
et al., 2013), peak synaptogenesis occurs during early postnatal life
(Pan and Gan, 2008).
The terminal periods of critical windows coincide with other
hallmarks of neurodevelopment (Figure 1C). These include the
progressive myelination of nerve ﬁbers, which is a process essen-
tial for cortical function; mice caged in isolation 2 weeks after
weaning show reduced myelin and diminished cortical func-
tion (Makinodan et al., 2012). Importantly, myelination is also
delayed in FXS (Pacey et al., 2013). Also relevant to ASD dis-
ease states is the emergence and maturation of local inhibitory
(I) interneurons coincident with the end of critical periods, to
provide balance to young excitatory (E) circuits (Figure 1C;
Hensch, 2004, 2005). The correct development of E/I ratio is crit-
ical to neural circuit output, and defects in the E/I ratio balance
is a leading candidate mechanism for explaining the emergence
of ASD disease states (Gatto and Broadie, 2010). Both hyperex-
citation and hypoinhibition are recurring themes in numerous
ASDmodels (Casanova, 2006). More generally, genetic disruption
of cortical interneuron development causes regional GABAergic
deﬁcits, epilepsy and ASD-like behavioral changes in mice (Powell
et al., 2003). As one example, mice deﬁcient for the axon guid-
ance receptor neuropilin 2 display reduced cortical interneuron
numbers and are more prone to seizure following neuronal exci-
tation (Gant et al., 2009). Thus, the critical period theory must
include the temporally phased regulation of ﬁrst excitatory and
then inhibitory synapses, such that A-D synapse selection gen-
erates the appropriate E/I synapse ratio balance. There are other
hallmarks of critical period cessation, including the A-D establish-
ment of the perineuronal network, a matrix of chondroitin sulfate
proteoglycans (Figure 1C; Ye and Miao, 2013). Roles of glycan
modiﬁcations in ASD models will be further discussed below in
Part 2.
ACTIVITY-DEPENDENT SYNAPSE MECHANISMS IN Drosophila
Synaptic ultrastructure and function is remarkably conserved
across species, for example, comparing mammalian brain glu-
tamatergic synapses to Drosophila NMJ glutamatergic synapses
(Schuster, 2006). Moreover, the underlying molecular elements of
synapses are similarly extremely well conserved, allowing mutu-
ally complementary studies in animals ranging from rodents to
ﬂies (Featherstone and Broadie, 2000; Koles and Budnik, 2012).
Most A-D work in Drosophila has focused on axonal (presy-
naptic) development (Rohrbough et al., 2003), whereas most
comparable work in mouse has focused on dendritic (postsynap-
tic) spines. However, the Drosophila NMJ postsynaptic domain
is well described and clearly subject to extensive A-D remodel-
ing. It contains two functional classes of ionotropic glutamate
receptors (iGluRs; Marrus et al., 2004) and a single metabotropic
glutamate receptor (DmGluRA; Bogdanik et al., 2004). Postsy-
naptically, iGluRs are trafﬁcked and stabilized downstream of
A-D mechanisms (Thomas and Sigrist, 2012), and in vivo imag-
ing has shown that presynaptic release of dense core vesicles is
A-D, with potentiation of release dependent on Ca2+ inﬂux and
CaMKII (Ca2+/calmodulin-dependent protein kinase II) activa-
tion (Shakiryanova et al., 2007). DmGluRA nulls show increased
A-D facilitation and decreased synaptic boutons of increased
size, suggesting the receptor acts as an activity monitor con-
trolling both synapse function and structure (Bogdanik et al.,
2004). DmGluRA loss leads to increased expression of iGluRs, and
DmGluRA over-expression leads to decreased iGluRs (Pan and
Broadie, 2007), demonstrating a tight regulation of postsynaptic
receptor composition as an activity response mechanism. These
A-D processes in the postsynaptic domain are directly impacted
in the Drosophila FXS disease model as discussed below in
Part 2.
The Drosophila NMJ is a particularly dynamic synaptic struc-
ture during early development, with A-D growth modulated
during larval crawling behavior and mediated via glutamatergic
neurotransmission (Schuster, 2006). Live imaging shows NMJ
growth proceeds by a variety of mechanisms: stretching of exist-
ing boutons and insertion of new boutons in between, adding
new boutons to the end of an existing strand, de novo addition and
branch formation fromexistingboutons (Zito et al.,1999). A crude
method to increase NMJ transmission is through chronic rearing
at 29–30◦C, which results in accelerated synapse growth (Sigrist
et al., 2003; Zhong andWu, 2004). Spaced depolarization via high
K+ saline application leads to the rapid extension and retrac-
tion of short ﬁlopodia, and the formation of synaptic boutons
(Ataman et al., 2006). Reduced membrane excitability via inward
current mutants (paralytic Na+ channel) or other Na+ channel
loss-of-function (tipE or mlenap−ts1) leads to improper synap-
tic reﬁnement (Jarecki and Keshishian, 1995; White et al., 2001),
with signiﬁcantly smaller synaptic boutons (Lnenicka et al., 2003).
Acute depolarization of the NMJ leads to the formation of “ghost
boutons,” that initially lack presynaptic active zones and postsy-
naptic iGluRs, which appear on a timescale of hours (Ataman
et al., 2006, 2008). Generation of genetically targetable channels,
such as the voltage-dependent UAS-EKO and UAS-Kir2.1 (Baines
et al., 2001; Paradis et al., 2001), and the constitutively open UAS-
dORK potassium channel shunt (White et al., 2001) allow a more
precise dissection of the effects of activity regulating NMJ synap-
tic morphology. Recent advances in bioengineering have taken
advantage of channel variants for genetically targeted hyperex-
citation in Drosophila, including the transient receptor potential
(TrpA1; Hamada et al., 2008) and TrpM8 thermogenic chan-
nels (Peabody et al., 2009), the constitutively active NaChBac
channel (Nitabach et al., 2006), the expanding family of chan-
nelrhodopsin (ChR2) variants (Schroll et al., 2006; Ataman et al.,
2008), and the hyperpolarizing eNpHR3.0 channel (Inada et al.,
2011). These new methods will be more fully described below in
Part 3.
Beyond neurotransmission per se, proper formation of the
Drosophila NMJ entails other A-D trans-synaptic signaling mech-
anisms. Wnt signaling via wingless (Wg; Packard et al., 2002;
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Korkut and Budnik, 2009) functions downstream of activity (high
K+ depolarization, ChR stimulation) to regulate both struc-
tural and functional development (Ataman et al., 2008; Korkut
et al., 2009). Similarly in mammals, activity regulates Wnt2
transcription, which stimulates dendritic arborization in hip-
pocampal cultures (Wayman et al., 2006). Bone morphogenetic
protein (BMP) signaling via glass bottom boat (Gbb; McCabe
et al., 2003; Keshishian and Kim, 2004) leads to NMJ stabiliza-
tion through LIM kinase 1 activity, preventing retraction and
synapse loss (Eaton and Davis, 2005). Recent use of Shaker K+
channel mutants (or raising temperature to 30◦C) to increase
excitability, shows that retrograde BMP signaling is required
for A-D NMJ growth and maturation (Berke et al., 2013). Hep-
aran sulfate proteoglycan (HSPG) co-receptors of such signaling
ligands (Ren et al., 2009), including Dally-like protein (Dlp)
and Syndecan (Sdc), play important roles in NMJ synapto-
genesis (Johnson et al., 2006; Dani et al., 2012). Importantly,
HSPGs interact closely with FMRP to modulate trans-synaptic
signaling in the Drosophila FXS disease model (Friedman et al.,
2013), suggesting a link to A-D processes. Laminin A (LanA) is
another extracellular synaptic protein of interest that is downreg-
ulated in response to activity to regulate synaptic architecture:
LanA expression is inversely correlated with NMJ size, and is
regulated by larval crawling activity, synapse excitation, post-
synaptic response, and Wnt signaling (Tsai et al., 2012). These
A-D processes in the presynaptic domain are directly impacted
in the Drosophila FXS disease model as discussed below in
Part 2.
Although A-D development has been explored at length at the
Drosophila NMJ,more limited studies have examinedA-Dmecha-
nisms in the brain, mainly focusing on the mushroom body (MB)
learning and memory center (Zars et al., 2000; Margulies et al.,
2005). These studies have been enhanced by recent generation of
more targeted Gal4 drivers and new optogenetic tools allowing
cell-autonomous, single-cell resolution dissection of A-D mecha-
nisms in normal and disease states (Chiang et al., 2011). Using
the mosaic analysis with a repressible cell marker (MARCM)
clonal technique (Lee and Luo, 2001), characterization of MB
axons shows critical period development at the level of individual
cells: synaptic branches display signiﬁcantA-D pruning during the
early-use period following eclosion, but become relatively static at
maturity (Tessier and Broadie, 2008). Importantly, sensory depri-
vation (SD) elevated synaptic branch number during this critical
period, whereas activity depolarization of single-cell MARCM
clones by ChR2 optical stimulation signiﬁcant decreased synaptic
branching during this same critical period (Tessier and Broadie,
2008). Similarly, recent work silencing olfactory sensory neurons
(via UAS-Kir2.1; Limb3b-Gal4 or UAS-DorK; Limb3b) lead to
immature axonal morphology, including broad axon terminals
and multiple ﬁlopodia (Prieto-Godino et al., 2012). Silencing of
a limited subset of projection neurons innervating the MB (UAS-
dORK1.deltaC; Mz19-Gal4) leads to increased size, number, and
active zone density of axon terminals within the microglumeruli
of the MB calyx (Kremer et al., 2010). These A-D processes
in the brain MB learning/memory center are directly impacted
in the Drosophila FXS disease model, as discussed below in
Part 2.
Information on A-D mechanisms regulating dendrites in the
Drosophila genetic model is more limited, but this research focus
is rapidly expanding. For example, motor neuron dendrite struc-
tural development has been shown to be regulated downstream of
high K+ depolarization (Hartwig et al., 2008; Zwart et al., 2013).
Moreover, a role for synaptic activity in dendritic remodeling has
been shown via targeted transgenic tetanus toxin expression (UAS-
TNT; Sweeney et al., 1995) blocking neurotransmitter release from
cholinergic interneurons (Cha-Gal4; UAS-TNT) leads to increased
dendritic structural complexity (Tripodi et al., 2008). Dendritic
reﬁnement in serotonergic neuron pupal development is also
modulated by activity: hyperpolarization via UAS-Kir2.1 caused
increased dendritic length, which was proposed to be due to A-D
Wnt/Wg signaling with a pro-retraction role in sensory-input
dendritic reﬁnement (Singh et al., 2010). Similarly, the silenc-
ing of olfactory sensory neurons (via UAS-Kir2.1; Orco-Gal4)
led to enhanced dendritic occupancy of the antennal lobe by
projection neurons (Prieto-Godino et al., 2012). However, it is
also clear that A-D differences may be found across different
neuronal types or developmental stages. For example, increased
ﬁring of RP2 motor neurons caused by dominant negative
Shaker and eag K+ channel mutations resulted in increased den-
dritic complexity, whereas Kir2.1 silencing resulted in decreased
dendritic structure (Timmermans et al., 2013). Moreover, consti-
tutively active CaMKII also led to increased dendrite length and
branching (Timmermans et al., 2013). Use of the temperature-
gated TrpA1 channel to activate neuron ﬁring demonstrated that
MN5 ﬂight motor neuron dendrites respond to activity differ-
ently over time: increased activity before pupal day 6 caused
decreased dendritic branching (Vonhoff et al., 2013), whereas
increased activity later in development caused increased branch-
ing (Duch et al., 2008), again suggesting differential A-D critical
periods.
Mammalian models of dendritogenesis display similar A-D
mechanisms to those characterized above inDrosophila. For exam-
ple, increased neural activity and glutamatergic signaling led
to dendritic spine outgrowth (Jontes and Smith, 2000; Antar
et al., 2006), and spine turnover rates in young mice were shown
to be sensory experience-dependent (Trachtenberg et al., 2002).
Long-term SD through whisker trimming led to dendritic spine
pruning that was more prominent in young mice (Zuo et al.,
2005), and spine synapse densities changed upon rearing or train-
ing in enriched environments (Greenough et al., 1985; Beaulieu
and Colonnier, 1987; Moser et al., 1995). Spaced depolariza-
tion of hippocampal neurons in culture led to extension of new
spines, a process correlated with A-D MAPK activation (Wu et al.,
2001). Recent advances in live imaging have elegantly provided
in vivo evidence of A-D dendritic spine dynamics (Alvarez and
Sabatini, 2007; Holtmaat and Svoboda, 2009). As one exam-
ple, the immediate early gene Arc/Arg3.1 functions to eliminate
surplus climbing ﬁbers (CF) onto Purkinje cell synapses in the
cerebellum, a process that is accelerated with ChR2 depolarizing
stimulation for 2 days and suppressed by targeted CF knockdown
of voltage-gated Ca2+ channels (Mikuni et al., 2013). Limited
regions of the adult brain remain amenable to similar changes,
for example, hippocampal spine density increased in adult rats
following spatial learning (Moser et al., 1995), and multiphoton
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imaging of dendritic spines during mGluR-induced long-term
depression (LTD) showed spine shrinkage and spine elimina-
tion that persisted for up to 24 h (Ramiro-Cortes and Israely,
2013), but in general these synaptic dynamics are conﬁned to
critical periods of synaptogenesis during deﬁned developmental
windows.
ACTIVITY-DEPENDENT TRANSCRIPTIONAL AND TRANSLATIONAL
REGULATION OF SYNAPTOGENESIS
Activity-dependent gene transcription clearly leads to develop-
mental changes in synaptic connectivity. Mouse studies of the
transcriptional regulator methyl CpG binding protein 2 (MeCP2)
are one elegant example, with knock-in mouse lacking the neu-
ronal activity-induced phosphorylation (NAIP) sequence showing
increased excitatory synaptogenesis (Li et al., 2011). MeCP2 is
phosphorylated in response to activity and subsequentCa2+ inﬂux
(CaMKII-dependent), leading to regulation of dendritic branch-
ing, spine morphogenesis, and A-D induction of brain-derived
neurotrophic factor (BDNF) transcription (Zhou et al., 2006).
Importantly,MeCP2-deﬁcient mice exhibit delayedmaturation of
cortical synaptogenesis and neuronal architecture defects (Fukuda
et al., 2005), and human MeCP2 mutations are causally associ-
ated with the ASD Rett syndrome (Amir et al., 1999). Indeed,
many ASD candidate genes are expressed synaptically to modu-
late synapse function/morphology, and are directly regulated by
synaptic activity (Zoghbi and Bear, 2012). Calcium inﬂux has a
profound impact on gene transcription (Greer and Greenberg,
2008). As one example, A-D Ca2+ inﬂux leads to dephosphoryla-
tion ofmyocyte enhancing factor 2 (MEF2) by calcineurin, causing
dissociation with histone deacetylases, CBP recruitment and
ultimately, transcription-dependent synapse elimination (Flavell
et al., 2006; Barbosa et al., 2008; Pulipparacharuvil et al., 2008).
MEF2 activation also leads to suppression of excitatory synapse
number via Arc (Flavell et al., 2006; Flavell and Greenberg, 2008),
perhaps through Arc-mediated AMPA receptor internalization
(Niere et al., 2012). This MEF2-regulated synapse elimination
has been correlated with the acquisition of learning and mem-
ory abilities (Barbosa et al., 2008), such as those impacted in
ASD disease states. Activity similarly regulates cAMP response
element-binding protein (CREB), serum response factor (SRF),
FBJ murine osteosarcoma viral oncogene (Fos; Greenberg et al.,
1986), and neuronal PAS domain protein 4 (NPAS4; Lin et al.,
2008), leading to the A-D transcriptional regulation of synaptic
proteins, including ASD-associated BDNF, Arc, and ubiquitin-
protein ligase E3A (Ube3A; Cohen and Greenberg, 2008; Greer
and Greenberg, 2008). CREB and NPAS4 transcriptional activ-
ity, via BDNF A-D activation, also leads to a reduced number of
inhibitory synapses on excitatory neurons (Hong et al., 2008; Lin
et al., 2008), suggesting roles in the developmental regulationof E/I
ratio.
Activity-dependent localized synaptic translation permits a
rapid and synapse-speciﬁc response, which is particularly impor-
tant in governing the multitude of differentially active synapses
occurring at a distance from the cell body. RNA-binding pro-
teins and translational regulation have been demonstrated in both
axonal growth cones andmature axons (Hornberg andHolt,2013),
ostensibly permitting local protein production in presynaptic
boutons. Highly motile RNA granules containing inactive ribo-
somes (Krichevsky and Kosik, 2001; Elvira et al., 2006), suggest
neurons have evolved mechanisms to bypass translation initia-
tion locally at the synapse (Costa-Mattioli et al., 2009; Batish et al.,
2012). Assays of local translation using ribopuromycylation to
visualize ribosomes associated with nascent peptide chains (David
et al., 2012) demonstrate that mRNAs are transported alongside
paused polyribosomes at hippocampal synapse, thereby bypassing
the rate-limiting step of translation initiation (Graber et al., 2013).
Importantly, these polyribosomes co-localize with RNA-binding
FMRP and Staufen 2 (Antar et al., 2005; Elvira et al., 2006; Napoli
et al., 2008; Darnell et al., 2011; Lebeau et al., 2011), and defects in
A-D translational control can lead to ASD states, with unregulated
translation causing synaptic impairment driving behavioral dys-
function (Santini et al., 2013). This topic will be explored at length
in Part 2.
The strongest link between translation control and A-D synap-
togenesis is the RNA-binding FMRP, which regulates translational
initiation (Napoli et al., 2008), mRNA transport (Bassell and
Warren, 2008), and translational elongation of mRNAs encod-
ing synaptic proteins (Darnell et al., 2011). FMRP is strongly
upregulated during critical periods of neural circuit reﬁnement,
where it associates with mobile RNA granules in dendrites, spines,
ﬁlopodia, and growth cones that translocate in response to the
level of neuronal activity (Antar et al., 2005; Cook et al., 2011).
Importantly, FMRP is positivity upregulated by neuronal activ-
ity (Antar et al., 2004; Gabel et al., 2004; Tessier and Broadie,
2008; Wang et al., 2008b), and regulates multiple A-D processes
including synapse elimination (Pfeiffer et al., 2010). Studies at the
Drosophila NMJ ﬁrst demonstrated that FMRP negatively reg-
ulates cytoskeletal targets, including the MAP1B/Futsch (Zhang
et al., 2001) mediator of microtubule-associated synaptic growth
(Roos et al., 2000). Interestingly, A-D transcriptional and transla-
tional control are linked through FMRP, as the activity of MEF2
in synapse elimination is wholly dependent on FMRP func-
tion, and occurs cell autonomously in the postsynaptic neuron
(Pfeiffer et al., 2010). In Fmr1 knockout (KO) hippocampal cul-
ture, acute expression of FMRP (via timed transfection) at an
early postnatal period leads to synapse growth, but FMRP dur-
ing the second postnatal week led to suppression of synapse
formation (Zang et al., 2013). Interestingly, MEF2 activity is pro-
gressively increased upon depolarization (via high K+ treatment)
over the same developmental period (Zang et al., 2013). These
recent studies highlight both the impact of FMRP on synap-
tic growth and the importance of developmental timing within
critical periods of development. In the following section (Part
2) we will elaborate the molecular details of FXS and other
ASDs, highlighting A-D changes in the development of synaptic
connectivity.
PART 2: ACTIVITY-DEPENDENT MECHANISMS IN ASD
DISEASE STATES
For ASD diagnosis, children must display three core symptoms
before 3 years of age: (1) atypical social behavior, (2) disrupted
verbal/non-verbal communication, and (3) unusual patterns of
restricted interests or repetitive behaviors (Geschwind and Levitt,
2007). It has been proposed that a “disconnect” between brain
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regions involved in higher-order associations lies at the root of
theseASDbehaviors (Frith,2004; Courchesne andPierce,2005; for
historical context, Geschwind, 1965a,b). For example, this discon-
nect may occur between a pair of higher-order association cortices
(or several such centers), which represent input from multiple
sensory modalities in cortical space (Geschwind and Levitt, 2007).
More evidence for this disconnect theory comes from prefrontal
cortex and anterior cingulate disconnection for joint attention
(foundation of language and social behavior; Mundy, 2003),
and demonstrated disconnect in functional magnetic resources
imaging (fMRI) studies (Koshino et al., 2005). The root of this
hypothesis is based on the hierarchical development of cortical cir-
cuitry (LeBlanc and Fagiolini, 2011; i.e., disrupted development of
the initial architecture, e.g., via shifts in critical periods) results in
faulty substrates for subsequent A-D mechanisms that are crucial
for reorganization, pruning, and solidiﬁcation of synapses within
circuits. Primary sensory cortices develop progressively, with crit-
ical periods that are variable in time and often non-overlapping
(Kroon et al., 2013). Furthermore, individual modalities develop
progressively, as the critical periods of rodent somatosensory cor-
tex begin at the subcortical level and then progress to cortical levels
(Feldmeyer et al., 2013). The“missedwindow”theory of ASDsmay
help explain the root of auditory, visual, and somatosensory dys-
function in information processing, which drives the socialization
and communication deﬁcits deﬁning ASDs (LeBlanc and Fagi-
olini, 2011). In terms of basic brain architecture,ASDsmay emerge
through faulty subcortical development, which precedes thalamic
as well as subsequent cortical development (Kroon et al., 2013).
Evidence for this theory includes early incidence of motor devel-
opmental delay, social impairment, and epileptic seizures (Zoghbi
and Bear, 2012).
The hierarchicalmodel of ASDbrain development is built upon
evidence that alterations in primary sensory modalities underlie
higher order cognition defects. Broadly speaking, these primary
sensory alterations appear to lessen in severity with age, although
the severity of primary sensory impairments clearly correlates
with the degree of social interaction impairment (Ben-Sasson
et al., 2009; Simmons et al., 2009). Neuronal activity is essential
for circuit development (Lendvai et al., 2000; Spitzer, 2006), and
this activity is both intrinsically generated (Golshani et al., 2009;
Rochefort et al., 2009) and sensory derived, as shown in primary
visual cortex (Siegel et al., 2012). However, this A-D component
of circuit development is obviously built upon genetic founda-
tions, and several hundred genes are associated with ASDs (State
and Sestan, 2012). Clinical characterizations of ASDs are highly
suggestive of A-D synaptic defects (Toro et al., 2010; Ebert and
Greenberg, 2013). For example, FXS patients display hypersen-
sitivity to numerous sensory stimuli (Miller et al., 1999), as well
as abnormal sensory gating in prepulse inhibition trials (Hessl
et al., 2009). In addition, attention deﬁcit/hyperactivity disorder
(Murray, 2010) and developmentally transient epilepsy are also
associated with FXS (Musumeci et al., 1999; Berry-Kravis, 2002)
strongly indicating a core A-D impairment.
Although it is understandably difﬁcult to model ASD behav-
iors in animals, several recent studies demonstrate inventive ways
to address this essential issue. For example, Fmr1 KO mice dis-
play many behavioral disruptions similar to human FXS patients,
including susceptibility to audiogenic seizure, hyperactivity, learn-
ing and memory deﬁcits, and social interaction abnormalities
(Kooy,2003; Bear et al., 2004;Hagerman et al., 2009). Some studies
report that Fmr1 KO mice show increased anxiety-related activ-
ity during social interaction (Mines et al., 2010), whereas other
studies show decreased anxiety in open ﬁeld studies (Michalon
et al., 2014). It is quite clear that behavioral phenotypic effects
are heavily dependent on genetic background (Spencer et al.,
2011). However, Fmr1 KO mice in the C57 background show
consistent impairments in social interaction behaviors (Baker
et al., 2010). Research in mice has also focused on single sensory
modalities, showing that Fmr1 KO mice display altered audi-
tory processing (Rotschafer and Razak, 2013). Although higher
cognition is difﬁcult to test in mice, recent research using a touch-
screen operant conditioning paradigm (which facilitates a con-
ﬂict between sensory-driven and task-dependent signals, thereby
increasing cognitive load) demonstrates that Fmr1 KO mice dis-
play defects in learning under heavy cognitive demand (Dickson
et al., 2013). The Drosophila FXS model similarly shows disrup-
tions closely resembling human FXS patients, including hyper-
activity, learning/memory deﬁcits, and social interaction abnor-
malities (Bolduc et al., 2008, 2010a,b; Coffee et al., 2010, 2012;
Tessier and Broadie, 2012).
CRITICAL PERIOD DEVELOPMENT OF E/I RATIOS IN ASDs
Autism spectrum disorders have been ascribed to altered E/I
synaptic balance,which likely reﬂects defects inA-D synapse elimi-
nation/addition speciﬁc to different classes of synapse (Rubenstein
and Merzenich, 2003; Hensch, 2005; Ramocki and Zoghbi, 2008;
Gatto and Broadie, 2010). Neural circuits must carefully bal-
ance excitatory and inhibitory connections during critical period
development, and theories of synaptic homeostasis posit that
compensatory alterations prevent runaway signaling (Turrigiano
and Nelson, 2004; Maffei and Fontanini, 2009). The appear-
ance of altered E/I ratio is linked with critical periods of brain
development, as runaway hyperexcitable circuits fail to mature
properly without inhibitory input (Rubenstein and Merzenich,
2003; Rippon et al., 2007). In support of this idea, postmortem
neocortex tissue from ASD patients shows reduced vertical arrays
of glutamatergic and GABAergic mini-columns and disordered
peripheral neuropil space (Casanova, 2006). Moreover, ASD post-
mortem studies reveal a reduction in glutamic acid decarboxylase
(GAD), the rate-limiting enzyme in GABA synthesis (Fatemi
et al., 2002). On the postsynaptic membrane, samples from ASD
patient brains also contain reduced GABA-A receptor expres-
sion (Fatemi et al., 2009a,b). Crucially, excitatory circuits must be
balanced byGABAergic inhibitory interneurons that formconnec-
tions progressively during late-stage critical period development
(Bacci et al., 2005). Competing theories of both hypoinhibi-
tion (GABAergic deﬁcits) and hyperexcitation (excitatory excess)
underlying autistic disease states are well known (Gatto and
Broadie, 2010). However, many results support hypoinhibition
models that complement hyperexcitation models; these models
are not necessarily mutually exclusive and may represent two
counterbalancing underpinnings of ASD disease states.
Fragile X syndrome is among the best-characterized ASD dis-
ease states. FMRP is found at the synapse, positivity upregulated by
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FIGURE 2 | Synaptic changes in the Fragile X syndrome disease state.
Schematic depictions of glutamatergic synapses in wild type (A) and FXS
(B) conditions showing molecular changes in the response to activity. Data
reﬂect human FXS patient studies, as well as mouse and Drosophila FXS
animal models. (A) In wild-type, FMRP regulates glutamate release and
anterograde trans-synaptic signaling (e.g., Jeb and Wnt), but does not
demonstrably affect retrograde signaling (e.g., BMP; Friedman et al., 2013).
FMRP acts as a translational repressor limiting synthesis of cytoskeletal
regulators (e.g., MAP1B, Rac1, PAK; Zhang et al., 2001; Bongmba et al.,
2011; Dolan et al., 2013), AMPA-R regulators (e.g., Arc; Costa et al., 2012;
Niere et al., 2012), MMPs (Bilousova et al., 2009), and heparan sulfate
proteoglycans (HSPGs: Dlp and Syd; Dani et al., 2012). FMRP is activity
regulated downstream of mGluR signaling, but likely responds to other
activity signals as well. (B) In the FXS state, lack of FMRP leads to
increased neurotransmission, increased HSPG production (which in turn
sequester anterograde trans-synaptic signaling molecules), increased MMP
synthesis/activity, cytoskeletal remodeling defects, and changes in
postsynaptic AMPA glutamate receptor cycling. Two engineered rhodopsin
variants allow non-invasive modulation of neural activity: channelrhodopsin
responds to 480 nm blue light to gate Na+ inﬂux (depolarization), and
halorhodopsin responds to 550 nm amber light to gate Cl− inﬂux
(hyperpolarization; Fenno et al., 2011).
neuronal activity and regulates A-D processes including synapse
elimination (Figure 2; Antar et al., 2004; Gabel et al., 2004; Tessier
and Broadie, 2008; Wang et al., 2008a; Pfeiffer et al., 2010). FXS
may be characterized by a failure to remove immature synaptic
connections and properly balance E/I synapse ratio during critical
period development (Comery et al., 1997; Irwin et al., 2000, 2001;
Galvez et al., 2005; McKinney et al., 2005). For example, Fmr1 KO
mice display brain-region speciﬁc increases and decreases in GAD
expression (D’Hulst et al., 2006; Adusei et al., 2010); increased in
cortex, brainstem, and diencephalon (El Idrissi et al., 2005), and
decreased in amygdala (Olmos-Serrano et al., 2010). FMRP also
regulates GABA-A receptor expression (Liu et al., 2013), as Fmr1
KOs show reduced GABA-R subunit mRNA (D’Hulst et al., 2006;
Gantois et al., 2006) and protein (El Idrissi et al., 2005; Curia et al.,
2009; Adusei et al., 2010). Recent work suggests that the timing
rather than the absolute expression levels of GABAARs α1, α2,
and gephyrin are altered in Fmr1 KO mice (Kratovac and Corbin,
2013), once again supporting the theory of critical period dys-
function. It is now clear that GABAergic changes are regionally
speciﬁc, as Fmr1 KO mice display reduced inhibitory synapses
within the basolateral amygdala (Olmos-Serrano et al., 2010), yet
increased inhibitory synapses are noted in CA1 region of hip-
pocampus (Dahlhaus and El-Husseini, 2010), providing direct
evidence of E/I imbalance. Fmr1-deﬁcient mice exhibit defects
in GABAergic neocortical circuits (Selby et al., 2007), with differ-
ences in the neocortical E/I balance (Gibson et al., 2008). There
is some conﬂicting data from functional GABAergic studies, with
decreased tonic inhibition in recordings from subicular neurons
(Curia et al., 2009), decreased tonic and phasic inhibition in the
amygdala (Olmos-Serrano et al., 2010), and increased inhibitory
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transmission in striatal spiny neurons (Centonze et al., 2008) all
reported in the mouse FXS model. A recent study reports a
cell-speciﬁc presynaptic role for FMRP in excitatory neurotrans-
mission onto inhibitory interneurons in layer 4 of mouse cortex
(Patel et al., 2013), withmicemosaic for Fmr1displaying decreased
glutamate release probability. This defect was not observed in
neurotransmission between excitatory neurons, showing a cell-
speciﬁc role for FMRP and a potential mechanistic basis for E/I
imbalance in the FXS disease state.
The opposing side of the E/I ratio – excitatory signaling – is even
better explored in ASD models, especially in the FXS disease state
(Rubenstein andMerzenich, 2003). Excitatory neurons are intrin-
sically more excitable in Fmr1 KO mice (Gibson et al., 2008), with
elevated Ca2+ signaling (Goncalves et al., 2013) and excitatory
networks that are structurally hyperconnected (although indi-
vidual excitatory connections are slower; Testa-Silva et al., 2012).
Excessive mGluR signaling, as a reporter of glutamatergic synapse
activity state, is widely reported (Bear et al., 2004; Bear, 2005).
The mGluR theory of FXS suggests that disease symptoms are due
to exaggerated downstream consequences of aberrant mGluR1/5
signaling. Crucially, FMRP is locally synthesized in response to
mGluR activation (Weiler et al., 1997), and mGluR-mediated hip-
pocampal LTD is exaggerated in Fmr1 KO mice (Huber et al.,
2002; Nosyreva and Huber, 2006). FMRP is dephosphorylated (by
PP2A) upon stimulation of group ImGluRs, which leads to a rapid
increase in translation (Narayanan et al., 2007). In line with these
studies, mGluR5 heterozygosity rescues many of Fmr1 KO mice
phenotypes (Dolen et al., 2007). Also, group 1 mGluR antagonists
[e.g., MPEP (2-methyl-6-(phenylethynyl)-pyridine)] ameliorate
several behavioral phenotypes in Fmr1 KO mice (Yan et al., 2005;
Choi et al., 2010b). Recent mechanistic studies show that mGluRA
activation starts a cascade of events leading to FMRP phosphory-
lation and subsequent synthesis of Arc, and ultimately mGluR-
associated LTD (Niere et al., 2012). In addition, activation of
serotonin 7 receptors (5-HT7) can reverse mGluR-induced AMPA
internalization in FXS model mice, effectively correcting mGluR-
LTD (Costa et al., 2012). Although initial formation of auditory
cortex is normal in Fmr1 KO mice, mutants fail to undergo
experience-dependent reorganization, suggesting an altered audi-
tory critical period that ismGluR-dependent, asMPEP suppressed
the sound-induced reorganization phenotype (Kim et al., 2013a).
Sensory-dependent reorganization of auditory cortex has been
explored at length, with A-D changes in hippocampus includ-
ing neurogenesis, learning and memory, and neural connectivity
(Chaudhury et al., 2013).
There are some caveats with the mouse FXS model. One issue
is the timing of the FMRP loss, as in mouse models the Fmr1
gene is deleted and therefore not expressed (Mientjes et al., 2006),
whereas the human gene is silenced viamethylation during embry-
onic development, but is expressed at early stages (Willemsen
et al., 2002). Furthermore, human patients may display Fmr1
mosaicism across cell types, due to methylation speciﬁcity or vari-
able presence of a premutation (Stoger et al., 2011). Finally, mouse
Fmr1 phenotypic effects are often surprisinglymild, transient, and
heavily dependent on genetic background (Spencer et al., 2011).
Although the Drosophila FXS model does not address the ﬁrst
two issues, dfmr1 null phenotypes are generally both more robust
andmore penetrant (Tessier and Broadie, 2012). Excitatory synap-
tic signaling (glutamatergic and cholinergic) pathways have both
been extensively studied in the Drosophila FXS model (Figure 2).
Electrophysiological studies indicate increased excitability, A-D
synaptic vesicle cycling and neurotransmission in dfmr1 null
glutamatergic synapses (Zhang et al., 2001; Gatto and Broadie,
2008). Drosophila FMRP and sole mGluR (DmGluRA) display
mutual feedback regulation, as FMRP expression increases with
the loss of dmGluRA, and DmGluRA expression increases with
loss of dfmr1 (Pan et al., 2008). Crucially, many FXS phenotypes
are ameliorated by feeding of mGluR antagonists (e.g., MPEP;
McBride et al., 2005; Choi et al., 2011), and MPEP phenocopies
the genetic loss of dmGluRA (Pan and Broadie, 2007; Pan et al.,
2008). Importantly, dfmr1; dmGluRA double null mutants par-
tially rescue excitatory defects witnessed under high frequency
stimulation paradigms (Repicky and Broadie, 2009), providing
a partial genetic basis for a hyperexcitable state in FXS. In the
absence of FMRP, increased mGluR function leads to decreased
cyclic AMP, which is further correlated with deﬁcits in olfactory
learning and memory (Kanellopoulos et al., 2012). Intriguingly,
cAMP positively regulates transcription of dfmr1, via PKA and
CREB (Kanellopoulos et al., 2012), thereby linking glutamater-
gic signaling and FMRP at the nucleus. In addition, recent work
in our laboratory has identiﬁed alterations in the inhibitory
circuitry of dfmr1 null ﬂies. dfmr1 mutants are characterized
by reduced GAD expression in the adult brain, developmen-
tal stage-speciﬁc dysmorphia in GABAergic axons innervating
the MB calyx, and altered GABAergic Ca2+ dynamics (Gatto
et al., 2014). This data importantly implicates altered inhibitory
neurotransmission in the Drosophila model of FXS, and fur-
ther validates the conservation of FMRP function in the fruit ﬂy
brain.
DYSMORPHIC SYNAPSES IN ASD DISEASE STATES
Most ASD human studies on synaptic dysmorphia focus on
the dendritic domain. For example, ASD patients display
increased dendritic spine densities on cortical projection neu-
rons (Hutsler and Zhang, 2010). FXS patients also display elevated
spine density, with processes displaying elongated, “tortuous”
structures (Irwin et al., 2001), perhaps suggestive of defects in
synapse elimination. Similar dendritic dysmorphia are common
in many other neurological disease states (Marin-Padilla, 1972;
Purpura, 1974; Kaufmann and Moser, 2000), which may reﬂect
developmental arrest or an attempted compensation for the lack
of functionally mature spines (Fiala et al., 1998). In particu-
lar, it should be noted that these dendritic phenotypes are not
restricted to the autism spectrum (sociolinguist deﬁcits), as indi-
viduals with schizophrenia (perception deﬁcits) and Alzheimer’s
disease (memory dysfunction) also display abnormal dendritic
spine architectures (Penzes et al., 2011). These three forms of
neurological dysfunction are distinct in symptomology, yet this
speciﬁcity may be rooted in the timing and onset of synaptic
dysfunction (Figure 1B).
Protrusiondynamics are just as important for synaptogenesis in
genetic model systems (Ziv and Smith, 1996; Luikart et al., 2008).
In the mouse FXS model, for example, there is delayed functional
spine formation in the hippocampus (Braun and Segal, 2000), and
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ultimately fewer spines with mature, bulbous morphology (Irwin
et al., 2000). SD leads to changes in spine protrusion dynamics in
neonatal mice (Lendvai et al., 2000), demonstrating A-D regula-
tion. Speciﬁcally, Fmr1KOmice deﬁcits may result from deﬁcits in
experience-dependent plasticity during critical periods of synaptic
reﬁnement (Dolen et al., 2007; Bureau et al., 2008). During in vivo
time lapse imaging through cranial windows in neonatal mice,
layer 2/3 neurons show a dramatic decrease in dendritic spine
dynamics during the ﬁrst 2 weeks as mushroom-shaped spines
replace ﬁlopodia and protospines, whereas Fmr1 KO mice show
developmental delays in the downregulation of spine turnover and
the transition to mature spines (Cruz-Martin et al., 2010). Impor-
tantly,mGluR blockage accentuated these phenotypes in Fmr1KO
mice (Cruz-Martin et al., 2010), providing a different link to A-D
synaptic remodeling in the FXS disease state.
The dynamic nature of dendrites enhances their ability to sam-
ple the extracellular space for suitable presynaptic terminals (Ziv
and Smith, 1996; Bonhoeffer andYuste, 2002). Immature synapses
from as adhesions between dendritic ﬁlopodia and axons (Fiala
et al., 1998). Perturbations in these dynamics lead to altered synap-
togenesis, for example, as demonstrated in Ephrin B-deﬁcient
(Kayser et al., 2008) and neurotrophin-deﬁcient (Luikart et al.,
2008) conditions. Following initial contact, spine dynamics are
necessary forA-D remodeling (Lendvai et al., 2000;Yuste andBon-
hoeffer, 2001, Yuste and Bonhoeffer, 2004; Holtmaat et al., 2006),
and then strongly downregulated at the end of the critical period
of synapse selection (Ziv and Smith, 1996). In FXS animal models,
the failure to stabilize dendritic spines in developmental critical
periods suggests Fmr1 null protrusions have problems main-
taining proper balance between stability and dynamism (Antar
et al., 2006; Pfeiffer and Huber, 2007), resulting in fewer mature
synaptic connections (Cruz-Martin et al., 2010). FMRP presum-
ably modulates synaptic stability through regulation of mRNAs
coding for dendritic spine regulators (Bagni and Greenough,
2005; Bassell and Warren, 2008), such as the key postsynap-
tic scaffold PSD-95 (postsynaptic density protein 95) as one
example (Figure 2; Zalfa et al., 2007). Recent reviews outline
the spine dysmorphia in the mouse FXS model in more detail
(He and Portera-Cailliau, 2013).
Differences in axonal development in the mouse FXS model
have not been as extensively studied. However, FMRP is local-
ized at axon growth cones, which are far less dynamic in Fmr1
KO mice (Antar et al., 2006). More thorough studies in the
Drosophila FXS model demonstrate progressive differences in
axonal projection and synaptic process pruning in the central
brain MB of dfmr1 null mutants (Tessier and Broadie, 2012).
The Drosophila model demonstrates defects in the development
of neuronal architecture (Zhang et al., 2001) and inappropriate
A-D pruning (Tessier and Broadie, 2009) throughout the brain.
For example, the synapses of small ventrolateral neurons (sLNvS)
in the circadian regulation circuitry are overelaborated in dfmr1
nulls (Dockendorff et al., 2002; Gatto and Broadie, 2009), a devel-
opmental phenotype that can be rescued only during the late
pupal/early adult critical period, but not in early pupal stages or
in mature adult stages (Gatto and Broadie, 2009), demonstrating
a transient critical period requirement for FMRP. In the MB cir-
cuit, FMRP is required to limit outgrowth during an early phase
and to subsequently prune synaptic branches in a later phase,
and both phases are dependent on activity input (Tessier and
Broadie, 2008). Furthermore, MB neurons in dfmr1 nulls demon-
strate age-dependent increases in calcium signaling dynamics,
as well as deﬁcient expression of several calcium-binding pro-
teins (Tessier and Broadie, 2011), suggesting activity is driving
a calcium signaling cascade coupling structural and functional
developmental changes in the FXS disease state. Collectively, these
defects all map to the early-use, A-D critical period of synaptic
remodeling.
A-D TRANSLATION MISREGULATION IN THE ASD FRAGILE X
SYNDROME
Autism spectrum disorders have been linked to hundreds of genes
(Abrahams and Geschwind, 2008; Toro et al., 2010; Devlin and
Scherer, 2012), and the number keeps jumping higher, with can-
didates in pathways affecting many distinct neuronal functions
(Delorme et al., 2013). Importantly, however, many of these genes
are modulated by neural activity, either directly or indirectly
(Morrow et al., 2008; Chahrour et al., 2012; Ebert and Greenberg,
2013), and a number are known to be involved in A-D neural cir-
cuit modiﬁcation (Toro et al., 2010). Rare de novo mutations have
implicated a large network of genes directly involved in synapto-
genesis and synaptic function (Gilman et al., 2011). Nevertheless,
ASD modeling is made difﬁcult by the underlying genetic diver-
sity, and this difﬁculty is compounded by the array of symptoms
described in human conditions and debates about appropriate
genetic models (Crawley, 2007). The genetic bases of autism can
be divided into a number of molecular groups: (1) chromatin
remodeling, (2) cytoskeletal dynamics, (3) synaptic scaffolds,
(4) neurotransmitter receptors and transporters, (5) second mes-
sengers, (6) cell adhesion molecules, and (7) secreted proteins
(Persico and Bourgeron, 2006). Clearly the genetic basis of ASDs
is massive area, and we focus here only on the FXS disease state,
which may be an A-D translation control point for a number of
these protein classes.
The monogenic FXS disease state (Verkerk et al., 1991) is typ-
ically caused by an unstable 5′ trinucleotide expansion in the
promoter region of the Fmr1 gene leading to hypermethylation
and transcriptional silencing (Leehey et al., 2008). FXS patients
exhibit delayed developmental trajectories, working memory
deﬁcits, circadian defects, hypersensitivity to sensory input,
seizures, increased anxiety and hyperactivity (Harris et al., 2008),
and a 30% comorbidity with autism (Zingerevich et al., 2009).
Furthermore, FMRP may be associated with other neurologi-
cal disease states, as schizophrenic patients have reduced FMRP
in the periphery (Kovacs et al., 2013) and cerebellum (Fatemi
et al., 2010), correlating with poor performance on perceptual
integration tasks (Kelemen et al., 2013). The expanding web of
FMRP associations (Bourgeois et al., 2009; Hagerman et al., 2010;
Fatemi and Folsom, 2011) underlines the importance of this
mRNA-binding translational regulator, with hundreds of candi-
date mRNA targets (Miyashiro et al., 2003; Darnell et al., 2011;
Bagni et al., 2012). FMRP forms large cytosolic ribonuclear parti-
cles (RNPs), which are associated with mRNA transport, stability,
and translation control (Bagni et al., 2012). RNP transport dynam-
ics are altered in Fmr1 KO mice, with reduced kinesin-associated
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mRNAs (Dictenberg et al., 2008). However, FMRP does not
appear to be necessary for steady-state maintenance or consti-
tutive localization of the majority of its target mRNAs (Steward
et al., 1998; Dictenberg et al., 2008), although direct measurement
of protein synthesis in hippocampal slices (Dolen et al., 2007),
hippocampal culture (Osterweil et al., 2010), and synaptosomes
(Muddashetty et al., 2007) shows global elevations in the Fmr1KO
mouse.
Fragile Xmental retardation protein is such an important focus
because it is poised to directly and quickly respond to activity
changes at the synapse. FMRP transports mRNA within the neu-
ron and speciﬁcally at synapses in an A-D manner via association
with microtubule-associated motor proteins (Kanai et al., 2004;
Antar et al., 2005; Ferrari et al., 2007; Dictenberg et al., 2008; Char-
alambous et al., 2013). Targets of FMRP (Billuart andChelly, 2003)
include the small GTPase Rac1 and its effector p-21 activated
kinase (PAK), functioning as actin regulators (Bokoch, 2003).
Rac1 is necessary for dendritic spine development, loss of FMRP
leads to over-activation of Rac1 (Figure 2B), and Rac1 pharma-
cological inhibition leads to suppression of LTD in Fmr1 KOmice
(Bongmba et al.,2011). In addition,A-D stimulationof hippocam-
pal synapses leads to increased phosphorylated PAK in wild-type,
but not Fmr1 KO mice, and mutants were unable to maintain
actin cytoskeletalA-D changes (Chen et al., 2010). Moreover, small
molecule inhibition of PAK suppresses Fmr1 null phenotypes
including dendritic spinemorphology, seizures, hyperactivity, and
repetitive movements (Dolan et al., 2013). Another target, PSD-
95 is an adaptor protein associated with glutamatergic receptors
(Sheng and Kim, 2002); mice deﬁcient in PSD-95 show den-
dritic spine dysmorphia in striatum and hippocampus (Vickers
et al., 2006). FMRP may regulate PSD-95 partially through sta-
bilization of PSD-95 mRNA, a process that is enhanced with
mGluR activation (Figure 2A; Zalfa et al., 2007). FMRP also
associates with futsch/MAP1B mRNA, a microtubule regulator
of synaptic growth (Roos et al., 2000), that can be localized at
the growth cone of developing axons (Antar et al., 2006), and
is localized within FMRP–RNP granules in cultured hippocam-
pal neurons (Antar et al., 2005). FMRP and futsch associate in
co-immunoprecipitation assays, and its expression is inversely
correlated with FMRP expression (Zhang et al., 2001). Impor-
tantly, futsch loss of function corrects the synaptic overgrowth
phenotype in dfmr1 nulls (Figure 2B; Zhang et al., 2001). Appli-
cation of the axon guidance molecule Semaphorin-3A (Sema3A)
to hippocampal culture leads to MAP1B protein synthesis, but
this response is attenuated in Fmr1 null neurons (Li et al., 2009),
thereby linking the activity of an axon guidance molecule with
local FMRP-dependent translation. More recent work has shown
that FMRP regulation of futsch is downstream of BMP and Spartin
signaling (Nahm et al., 2013), thereby linking a key trans-synaptic
signaling pathway with cytoskeletal changes in presynaptic
neurons.
Several recent studies have provided new mechanistic insights
about FMRP function at the synapse. Two recently identiﬁed
FMRP targets are striatal-enriched protein tyrosine phosphatase
(STEP) and amyloid precursor protein (APP), which appear to
underlie at least a portion of mouse Fmr1 phenotypes, as genetic
reduction of either can suppress audiogenic seizure, anxiety, and
social deﬁcits in the disease model condition (Westmark et al.,
2011; Goebel-Goody et al., 2012; Figure 2). Another target of
FMRP is Arc mRNA (Zalfa et al., 2003), an A-D immediate
early gene (Link et al., 1995) strongly linked to synaptic func-
tion (Park et al., 2008). Importantly, Arc protein functions to
stimulate endocytosis of AMPA glutamate receptors (Chowd-
hury et al., 2006), an action correlated with the A-D induction
of LTD (Park et al., 2008). FMRP plays an important modula-
tory role in this A-D process, acting as a translational repressor
of Arc synthesis during mGluR-LTD (Niere et al., 2012). FMRP
also regulates several potassium ion channels. For example, FMRP
interacts with Kv3.1b mRNA in brainstem synaptosomes, and the
A-D increase in Kv3.1b channel expression in wild type mice
is abolished in Fmr1 null mice (Strumbos et al., 2010). More-
over, FMRP can directly interact with potassium channel proteins
to regulate channel kinetics, including Slack channels (Brown
et al., 2010) and the β4 subunit of BK channels (Deng et al.,
2013). Therefore, FMRP can no longer be described as solely a
translational regulator, with protein–protein interactions regulat-
ing excitability demonstrating an additional vital role for FMRP
function.
The ﬁnal area of focus for FMRP regulation lies in the extracel-
lular space. Both mouse and Drosophila FXS models have recently
been documented to show large increase in the levels of synap-
tic matrix metalloproteases (MMPs), a family of extracellular
proteases involved in synaptic development, function, and plas-
ticity (Figures 2A,B; Rivera et al., 2010). MMPs cleave secreted
as well as membrane-anchored proteins during synaptogenesis
and A-D synaptic remodeling (Ethell and Ethell, 2007). Speciﬁ-
cally, MMP-9 expression and activity are increased in Fmr1 KO
mice (Bilousova et al., 2009), with MMP-9 locally translated at
synaptodendritic domains in anA-Dmanner (Dziembowska et al.,
2012). MMP-9 mRNA is transported and regulated by FMRP,
and increased MMP-9 expression is found in Fmr1 null synap-
tosomes frommouse hippocampus (Janusz et al., 2013). Crucially,
a drug inhibitor of MMPs,minocycline, effectively restores synap-
tic architecture and behavioral defects in the mouse FXS model
(Figure 2; Bilousova et al., 2009). The mechanistic link between
MMPs and ASDs may lie with MMP substrates, especially the
HSPGs, which are well-established proteolytic targets of MMPs
(Choi et al., 2012). HSPGs bind a variety of molecules, including
growth factors, morphogens, and cell surface receptors, effectively
modulating a hosts of biological functions (Bishop et al., 2007). In
BTBR autism mouse models (Scattoni et al., 2011), hippocampal
sclerosis (HS) immunoreactivity is reduced (Meyza et al., 2012).
Conditional inactivation (neuronal speciﬁc) of Ext1, an essential
enzyme for HS synthesis, leads to defective glutamatergic neu-
rotransmission and behavioral abnormalities similar to autistic
phenotypes (Irie et al., 2012). Disruption of HSPGs in Drosophila
leads to trans-synaptic signaling defects at the NMJ (Dani et al.,
2012), causing impairments of synaptic structural and functional
development. Moreover, in the Drosophila FXSmodel, bothMMP
mutation and the minocycline MMP inhibitor (MMPIs) treat-
ment effectively suppresses synaptic architecture defects in motor
neurons, clock neurons, and neurons of the central brain MB
learning/memory center (Siller and Broadie, 2011). Perhaps link-
ing these two mechanisms, the Drosophila FXS model displays
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dramatic upregulation of synaptic HSPGs (Figure 2), including
a GPI-anchored Glypican and transmembrane Syndecan (Sdc;
Friedman et al., 2013). These elevated co-receptors in turn inap-
propriately sequester Jelly Belly (Jeb) and Wnt Wg trans-synaptic
signaling ligands to alter intercellular communication between
pre- and postsynaptic cells during synaptogenesis (Figures 2A,B).
Genetic correction of the synaptic HSPG upregulation in dfmr1
nullmutants corrects both structural overelaboration and elevated
neurotransmission (Friedman et al., 2013), demonstrating this sig-
naling mechanism to be causative to A-D synaptogenic defects in
this FXS disease state model. Based on these extensive studies
in mice and ﬂies, MMPIs are currently in development for FXS
therapeutics as discussed below.
ASD THERAPEUTIC AVENUES
The A-D model of ASDs, especially as it applies to the regula-
tion of critical period development of appropriate E/I synaptic
ratios, suggests a number of therapeutic strategies. For exam-
ple, the overabundant mGluR signaling theory underlying FXS
dysfunction is supported by numerous mGluR mutant studies
in mouse and Drosophila animal models (Bear et al., 2004, 2008;
Bear, 2005; McBride et al., 2005; Dolen et al., 2007, 2010; Pan and
Broadie, 2007; Dolen and Bear, 2008; Pan et al., 2008; Repicky and
Broadie, 2009). Importantly, mGluR antagonists (such as MPEP)
effectively rescue many of the mouse and Drosophila FXS model
cellular and behavioral defects associatedwith FXS (McBride et al.,
2005; Pan and Broadie, 2007; Bolduc et al., 2008; Dolen and Bear,
2008; Choi et al., 2010a; Dolen et al., 2010). MPEP is not avail-
able for human use due to toxicity, but new generation mGluR
antagonists are in development (Levenga et al., 2010; Wang et al.,
2010b; Pop et al., 2013). For example, chronic application of the
mGluR antagonist CTEP suppresses learning andmemory deﬁcits
and leads to regional improvements in brain function in Fmr1 KO
mice, as determined by perfusion imaging as an indirect measure
of neural activity (Michalon et al., 2014), although it is important
to note that CTEP also affected wild-type learning and memory.
This ﬁrst use of functional imaging in a mouse ASD model is an
important step forward. Current FXS patient clinical trials include
other mGluR antagonists (e.g., mavoglurant; Gantois et al., 2013)
as well as GABA-B receptor agonists (e.g., arbaclofen; Henderson
et al., 2012). Fenobam, a selective mGluR antagonist, improved
prepulse inhibition in 6 of 12 FXS patients (Berry-Kravis et al.,
2009).mGluR reverse agonists inphase II and III clinical trialswere
recently extended to younger children (Levenga et al., 2010), recog-
nizing the early developmental focus likely necessary for effective
intervention. For illustration, the rescue of spine morphology
in cultured neurons from Fmr1 KO mice by mGluR blockage is
effective in young neurons but less so in older neurons (Su et al.,
2011). Thus, it is important for interventions to target A-D critical
periods.
On this opposing side of the E/I balance lies the therapeutic
potential to increase GABA levels or potentiate GABA recep-
tors, with the goal to alleviating FXS symptoms of hypoinhibition
(Paluszkiewicz et al., 2011; Coghlan et al., 2012). Altered GABAer-
gic inhibition is a common thread in many neurodevelopmental
disorders and represent an important focus for therapeutics.
Pharmacological approaches to GABAergic modulation address
several components of inhibitory neurotransmission, includ-
ing the GABA reuptake blockers Riluzole (Mantz et al., 1994;
Jahn et al., 2008; Erickson et al., 2011b) and Tiagabine (Nielsen
et al., 1991), GABAAR activators Ganaxolone (Biagini et al., 2010;
Reddy and Rogawski, 2010) and Gaboxadol (Deacon et al., 2007;
Lundahl et al., 2007; Olmos-Serrano et al., 2010), GABABR
activator Arbaclofen (Pacey et al., 2009), and Vigabatrin, an
inhibitor of GABA catabolism (French et al., 1996; Coppola et al.,
1997). Acamprosate is also interesting, as a drug that both
antagonizes mGluR5 (Blednov and Harris, 2008) and agonizes
GABAARs (Mann et al., 2008). A small uncontrolled trial with
three adult FXS patients showed improvement in social behavior
and communication after 16–28 weeks on acamprosate (Erick-
son et al., 2010), and similar gains in social communication
were found in a small uncontrolled sample of autistic children
(Erickson et al., 2011a).
Alternative pharmaceutical approaches to FXS focus on MMP
and perhaps HSPG function in the synaptomatrix (Siller and
Broadie, 2011; Dani and Broadie, 2012; Dani et al., 2012; Friedman
et al., 2013). One obvious approach is the use of MMPIs, of which
a large collection has been developed for human clinical trials on
inﬂammatory and vascular diseases (Hu et al., 2007). For example,
the tetracycline-derivative minocycline acting as an MMPI spurs
maturation of hippocampal dendritic spines and represses anxi-
ety andmemory defects in the FXSmouse model (Bilousova et al.,
2009), and similarly suppresses synaptic architecture defects in
motor neurons, clock neurons, and MB learning/memory center
neurons in the Drosophila FXS model (Siller and Broadie, 2011).
The drug therefore offers a directed approach toward deﬁcits in
A-D mechanisms at the synapse as it aims to correct overac-
tive MMP in the absence of FMRP. Minocycline has previously
been successful in treating a variety of neurological disorders,
including multiple sclerosis, Huntington’s disease, Parkinson’s
disease, and Alzheimer’s disease (Wang et al., 2003; Choi et al.,
2007; Kim and Suh, 2009). Minocycline treatments led to a long-
term reduction in hyperactivity and audiogenic seizures in young,
but not old mice (Dansie et al., 2013). In human trials, minocy-
cline led to improved language, behavior, and attention in FXS
patients in an uncontrolled study (Utari et al., 2010), and a recent
3-month double-blind, placebo-controlled trial with young FXS
patients showed improvements in anxiety, mood, and clinical
global impression (CGI) of FXS individuals given minocycline
(Leigh et al., 2013). The mechanistic link between minocy-
cline and MMPs in human patients has also been explored, as
reducedMMP-9 activity correlateswithCGI improvements in FXS
patients (Dziembowska et al., 2013). Finally, the PAK-associated
cytoskeletal changes in FXS models have been pharmaceutically
targeted, with signiﬁcant suppression of FXS phenotypes in the
Fmr1 null mouse (Dolan et al., 2013). There may be a clini-
cal path forward targeting PAK and/or downstream cytoskeletal
perturbations.
A quite different avenue for ASD treatment targets A-D critical
period development via environmental enrichment and train-
ing intervention following early diagnosis (Dawson et al., 2010;
Woo and Leon, 2013). To illustrate the impact of environmen-
tal input on cognitive development, Romanian orphans who
received limited sensory stimulation can have profound social and
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cognitive defects, andmanydeveloppost-institutional autistic syn-
drome (Hoksbergen et al., 2005), suggesting that an ASD-like state
can be achieved through purely environmental impoverishment.
Thankfully many of these children make signiﬁcant cognitive
and social gains upon adoption and placement into enriched
environments (Nelson et al., 2007). Importantly, enriched envi-
ronments increase sensory input activity andhave profound effects
on A-D synaptic dynamics (Greenough et al., 1985; Beaulieu and
Colonnier, 1987; Moser et al., 1995). In animal models, FXS
mutant mice display a host of striking improvements when reared
in enriched environments, including greater spine hippocam-
pal spine density (Lauterborn et al., 2013) and improved spike
timing long-term potentiation (LTP; Meredith et al., 2007). As
a group of syndromes with strong links to A-D synaptic devel-
opmental defects, enrichment approaches are popular in ASD
treatments (Reichow and Volkmar, 2010; Warren et al., 2011).
For example, a peer-mediated theater-based intervention strat-
egy for ASD children showed signiﬁcant gains in core social
deﬁcits (Corbett et al., 2013). Similarly, a recent 6-month con-
trolled trial showed signiﬁcant gains in autistic children who
underwent sensorimotor enrichment through olfactory and tac-
tile stimulation and exercises for other cross-sensory stimulation
(Woo and Leon, 2013). These behavioral intervention strategies
are, crucially, focusing on multisensory domains and may enable
great improvements in both social and cognitive abilities of ASD
children.
PART 3: IN VIVO MANIPULATION/READOUT OF
ACTIVITY-DEPENDENT CHANGES
The recent emergence of tools to non-invasively drive andmonitor
neural activity represents a pioneering step forward for A-D neu-
rodevelopmental studies. Compared to the relatively narrow and
invasive strategies of traditional electrophysiology (Biran et al.,
2005; Bjornsson et al., 2006), new optogenetic techniques provide
simultaneous access to groups of neurons, which can be selec-
tively targeted with a range of transgenic drivers (Kim and Jun,
2013). On the one hand, new optogenetic techniques using engi-
neered rhodopsin variants have enormously advanced our ability
to control activity with pulsed application of speciﬁc wavelengths
of light in deﬁned populations of neurons (Fenno et al., 2011).
On the other hand, optical recording techniques, such as cal-
cium sensors and voltage-sensitive ﬂuorescent reporters, provide
individual and massed readouts of neural activity throughout the
imaged circuitry, albeit at a cost in sensitivity and temporal reso-
lution compared to electrophysiological recordings (Grienberger
and Konnerth, 2012; Mutoh et al., 2012). Thus, these new trans-
genic techniques provide unprecedented abilities to both drive and
record in vivo neural activity, and therefore show great promise for
the systematic dissection of A-D critical period mechanisms at the
heart of ASD disease states.
Techniques for detecting neural calcium ﬂux have been pro-
gressing for decades (Shimomura et al., 1962; Tsien et al., 1985),
taking advantage of Ca2+ dynamics as a readout of neural activity
(Berridge et al., 2003). Resting Ca2+ concentrations in neurons
are typically <100 nM and rise 10- to 100-fold following a sin-
gle action potential (Berridge et al., 2000), providing the ability to
monitor spike number, timing, frequency, and levels of synaptic
input (Yasuda et al., 2004). Genetically encoded calcium indica-
tors (GECIs), such as the frGECIs and GCamps (Kotlikoff, 2007),
have revolutionized in vivo Ca2+ imaging. The latest generations
of GCamp sensors are especially exciting, as they display ultra-
sensitive kinetics and stably provide readout of neural activity
over extensive periods of time (Akerboom et al., 2012; Chen et al.,
2013). For instance, GCamp6 effectively records neural activity
from large groups of neurons to small synaptic compartments, in
animals ranging from Drosophila to mice (Chen et al., 2013). The
recent development of red-shifted GECIs reduces tissue scatter-
ing, phototoxicity, and background ﬂuorescence, and allows the
simultaneous use of other tools, such as ChR2, which is activated
with 480 nm light and would therefore overlap and interfere with
traditional green ﬂuorescent protein (GFP)-based calcium sensors
(Akerboom et al., 2013). The tandem development of multipho-
ton imaging and GECIs now provide exquisite access for activity
monitoring.
Although Ca2+ imaging serves as readout for diverse forms
of A-D changes (e.g., depolarization, inﬂux, store release, second
messenger cascades), the direct detection of changes inmembrane
voltage would represent a more speciﬁc, direct readout of elec-
trical activity. Small ﬂuorescent hydrophobic dyes have long been
able to detect changes in membrane potential, and can also be
used to characterize propagation of electrical signals through a
given circuit (Salzberg et al., 1973). However, these dyes have low
penetrance to deep areas of the brain, and are not genetically tar-
getable. Early generations of genetically encoded voltage indicator
proteins (GEVIs) overcame some of these limitations (Siegel and
Isacoff, 1997; Barnett et al., 2012), but failed to reliably demon-
strate robust signals in intact animals. In contrast, the recently
developed ArcLight system is a voltage sensor probes (VSP)-based
ﬂuorescent voltage sensor with greatly increased signal-to-noise
ratio (Jin et al., 2012). In intact Drosophila brains, the ArcLight
system effectively reports both action potentials and subthresh-
old events, demonstrating beautiful sensitivity (Cao et al., 2013).
The in vivo applications for this new tool are exciting. For exam-
ple, ArcLight has provided the ability to record rhythmic activity
in Drosophila clock neurons, which have so far been inacces-
sible to electrophysiology approaches (Cao et al., 2013). Thus,
GEVIs and GECIs are exciting new tools that grant non-invasive
and increasingly penetrant representations of in vivo neural
activity.
OPTOGENETIC CONTROL OF NEURONAL ACTIVITY
Optogenetic techniques have revolutionized the ability to direct
and dissect A-D processes during critical period develop-
ment (Williams and Deisseroth, 2013). Delivery of engineered
rhodopsin variants into targeted neurons provides a non-invasive
means to control neuronal ﬁring rates via pulses of speciﬁc wave-
lengths of light. ChR2 facilitate depolarization of the membrane
by gating inﬂux of Na+ ions when illuminated by blue light
(see Figure 2A; Fenno et al., 2011). Conversely, halorhodopsins
(eNpHR) respond to amber light by mediating Cl− ion inﬂux,
thereby hyperpolarizing the membrane and inhibiting ﬁring
(Figure 2A; Zhang et al., 2007; Gradinaru et al., 2008). To date,
most optogenetic studies have been either electrophysiological or
behavioral work in mature animals including, for example, an
Frontiers in Cellular Neuroscience www.frontiersin.org January 2014 | Volume 8 | Article 30 | 13
Doll and Broadie Activity-dependent mechanisms in ASDs
alternative to deep brain stimulation in Parkinson’s disease model
mice (Gradinaru et al., 2009), reduction of anxiety (Tye et al.,
2011), serotonergic modulation of behavior (Warden et al., 2012),
dopaminergic depression alleviation (Tye et al., 2013), and mem-
ory extinction (Van den Oever et al., 2013). However, develop-
mental applications of optogenetic A-Dmodulation are beginning
to appear. For example, ChR2-expressing Drosophila MB neu-
rons respond to short blue light illumination (6 h) during critical
period development with signiﬁcant decreases in synaptic process
branching, but this A-D synaptic pruning is completely abolished
in FXSmodel animals (Tessier and Broadie, 2008, 2012). Inmouse,
ChR2 optogenetic stimulation causes a lasting increase in postsy-
naptic spine density and increased concentrationof CaMKII,when
pairedwith glutamate uncaging (Zhang et al., 2008). Furthermore,
optogenetics is now capable of producing cortical maps, and can
be coupled with Ca2+ imaging for readouts of activity alterations
(Patterson et al., 2013). In addition, the coupling of optogenetic
stimulation and immediate early active gene NPAS4 mRNA facil-
itates identiﬁcation of transfected neurons in mice (Bepari et al.,
2012). The capacity to manipulate A-D neuronal structure and
function in vivo in a developmental context is simply remarkable,
and recent studies highlight the promise of these rapidly evolving
techniques.
In the past year, optogenetics techniques have particularly
begun to blossom. For example, delivery of ChR2 to thalamic
neurons was recently shown to effectively silence cortical seizures
in mice (Paz et al., 2013). Conversely, expression of eNpHR in
hippocampal neurons also provided protection against seizures
(Sukhotinsky et al., 2013). Halorhodopsin channels can also pro-
vide in vivo inhibition of motor activity (Liske et al., 2013). The
emergence of red-shifted GECIs and optogenetic channels now
facilitates dual transgenic manipulation and functional readout
in the same animal (Akerboom et al., 2013). Combinatorial dye
labeling can also facilitate the simultaneous detection of structural
and functional changes without the use of genetics (Siegel and
Lohmann, 2013). The development of optochemical G protein-
coupled receptors (GPCRs), including light-agonized mGluRs,
have been shown to be fast, bistable means to effectively sup-
press excitability and inhibit neurotransmitter release both in
brain slices and in vivo (Levitz et al., 2013). The InSynC (inhi-
bition of synapses with chromophore-assisted light inactivation)
technique has been developed to directly inhibit neurotransmit-
ter release, via a genetically encoded singlet oxygen generator
(miniSOG) fused to two synaptic proteins, vesicle-associated
membrane protein 2 (VAMP2) and synaptophysin (Lin et al.,
2013b). Multiphoton uncaging of glutamate and GABA analogs
has been demonstrated on individual dendritic spines in hip-
pocampal slices (Hayama et al., 2013). Red-shifted excitatory
optogenes (ReaChR) have improvedmembrane trafﬁcking, higher
photocurrents and faster kinetics, scatter less in passing through
the tissue, and have been capable of driving action poten-
tials in awake mice with illumination through the intact skull
(Lin et al., 2013a).
Despite the justiﬁable excitement, it is important to note also
important caveats to optogenetic applications, particularly for the
use in A-D developmental studies. First, it was recently reported
that long-term expression of ChR2 can alter axonal morphology
in mice (Miyashita et al., 2013). In addition, high-level, long-term
expression of ﬂuorescent probes can lead to structural artifacts
and phototoxicity (Packer et al., 2013). Second, optogenetics are
generally delivered through viral means in mammalian models,
and it has recently been reported that adeno-associated viruses
(AAVs) can form tissue deposits after injection, which can lead
to continued infection over time and alterations in the expres-
sion of the optogene (Packer et al., 2013). This problem may be
avoided with single cell electroporation (Judkewitz et al., 2009),
but this limits the applications. Third, extreme stimulation can
lead to an exhaustion of synaptic transmission (Kittelmann et al.,
2013). Therefore, it is important to modulate the expression and
long-term, high frequency use of optogenes, and to use appro-
priate controls to detect any artifacts. Alternative approaches
to optogenetics include the use of genetically targeted TrpA1
channels, which are a class of temperature-gated excitatory
cation channels for depolarizing neurons (Viswanath et al., 2003;
Dhaka et al., 2006; Hamada et al., 2008). Work in Drosophila
illustrates the power of TrpA1 manipulations, speciﬁcally in
comparison to ChR2 optogenetics, as neurons expressing TrpA1
can show stronger and longer lasting electrophysiological effects
(Pulver et al., 2009).
Drosophila METHODS FOR STUDYING A-D DEVELOPMENTAL
MECHANISMS
The “relative” simplicity of the Drosophila brain (hundreds of
thousands of neurons) provides a high level of understanding
about clonal lineages and connectivity among small, deﬁned pop-
ulations of neurons, even down to the individually identiﬁed
single neuron level (Chou et al., 2010; Chiang et al., 2011; Lovick
et al., 2013; Takemura et al., 2013;Wong et al., 2013). Importantly,
Drosophila genetics allows precise delivery of transgenic tools to
these targeted neuronal populations using the GAL4/UAS bipar-
tite system (Jones, 2009), and with the MARCM technique for
clonal analysis down to the individually identiﬁed single neu-
ron level (Lee and Luo, 2001; Ostrovsky et al., 2013). Our lab
has utilized these techniques particularly to analyze individually
identiﬁed neurons in the FXS disease model (Pan and Broadie,
2007; Tessier and Broadie, 2008; Gatto and Broadie, 2009; Siller
and Broadie, 2011), as our best-deﬁned Drosophila ASD model.
More recently,Drosophilahas gained an expansive catalog of highly
selective neuronal GAL4 drivers, which utilize limited regulatory
sequences for exquisitely limited expression (Jenett et al., 2012;
Manning et al., 2012). These new tools are providing the capacity
to target deﬁned neuronal circuits within the Drosophila brain at
a never-before achieved level of resolution. The use of selective
drivers for high-resolution morphological readouts of individual
neurons, in combination with non-invasive methods of activity
modulation,will greatly enhance our understanding of A-Dmech-
anisms of synapse remodeling. We predict that the utilization of
these new classes of neural drivers (in MB, projection neuron,
fan body, ellipsoid body, retina, etc.), in combination with both
optogenetic and alternative activity modulation techniques, will
providemuch better dissection of neuron class-speciﬁcA-D devel-
opmentalmechanismswithin the next few years. These studieswill
lead to a deeper understanding of ASDmodel disease states within
precise maps of brain circuits, such as the MB (Parnas et al., 2013;
Frontiers in Cellular Neuroscience www.frontiersin.org January 2014 | Volume 8 | Article 30 | 14
Doll and Broadie Activity-dependent mechanisms in ASDs
Perisse et al., 2013) and antennal lobes (Tanaka et al., 2012), which
will provide a foundation for deciphering the molecular genetic
bases of these disease states and engineering effecting treatment
strategies.
What are the current limitations on this use of the Drosophila
system? For optogenetics, Drosophila requires an essential co-
factor, all-trans retinal (ATR), for ChR2 activation (Schroll et al.,
2006; Ataman et al., 2008), although this feature does provide a
useful control. Moreover, ﬂuorescent tags on optogenetic channels
label targeted neurons to grant cell-autonomous morphological
readouts of A-Dmodiﬁcations, but fail to illuminate their synaptic
partners, although clevermapping techniques are being developed
[e.g., Genetic Reconstitution Across Synaptic Partners (GRASP);
Feinberg et al., 2008]. For example, the GRASP technique was
recently used to synaptically link MB Kenyon cells with modula-
tory aminergic neurons (Pech et al., 2013). In a similar fashion,
the CaLexA (calcium-dependent nuclear import of Lexa) neu-
ral tracing method may be useful for mapping synaptic partners
(Masuyama et al., 2012). Alternatively, synaptic mapping stud-
ies may be more suited for larger subsets of neurons (broader
GAL4 drivers), which are coupled to known targets and could
then be assayed through standard immunohistochemistry. Further
downstream, the use of immediate early neural genes, may help
illuminate downstream effects of activitymodulation (e.g.,Dhr38;
Fujita et al., 2013). Importantly, use of the multiple methods now
available forA-Dmanipulations duringneurodevelopmental stud-
ies (e.g., ChR2, eNpHR, TrpA1, NaChBac) in the Drosophila FXS
model can be used to directly test whether targeted brain cir-
cuitry is capable of responding appropriately to activity during
deﬁned developmental critical periods. Moreover, the capacity
to genetically target subsets of neurons may allow suppression
of downstream ASD-related phenotypes. For example, in the
Drosophila FXS model, hypoinhibition (e.g., reduced GABAer-
gic input) might be suppressed by increased depolarization of
inhibitory interneurons using a GAD:Gal4 driver crossed to ChR2,
and hyperexcitation (e.g., elevated mGluR activity) could simi-
larly be suppressed by selectively hyperpolarizing speciﬁc groups
of glutamatergic neurons with halorhodopsin. Such studies in the
particularly well-characterized Drosophila FXS model could ulti-
mately lead to new intervention strategies in FXS patients and, by
extension, the treatment of other patient groups suffering ASDs.
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